RN7SL795P

Across TCGA pan-cancer cohorts, RN7SL795P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RN7SL795P data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RN7SL795P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL795P expression acts as an unfavorable survival marker, although some lineages such as ESCA and SKCM show a favorable association.

CESC, MESO, and KIRP are the cancer types where RN7SL795P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	II,III,IV	0.146	0.759	.004	72	view →
MESO	OS	Tertile	III,IV	0.261	0.591	.015	72	view →
KIRP	OS	Tertile	All	0.703	0.894	.005	21	view →
THYM	DFS	Tertile	II,III,IV	0.621	0.933	.009	18	view →
KIRC	DFS	Tertile	All	0.157	0.630	.004	12	view →
ESCA	DFS	Tertile	III,IV	0.592	0.282	.030	9	view →
SKCM	OS	Tertile	III,IV	1.000	0.689	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RN7SL795P–CESC (OS)

Open the CESC breakdown →